| RS1447282271 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Intellectual disability |
| RS144729980 |
FANCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group L |
| RS144730090 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS144730815 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia 1, Cardiovascular phenotype |
| RS1447308562 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, BMPR1A-related disorder |
| RS144730861 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS1447311755 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1447313633 |
ZNF142
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with impaired speech and hyperkinetic movements, Neurodevelopmental disorder with impaired speech and hyperkinetic movements |
| RS144731446 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Acute myeloid leukemia |
| RS144731702 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS144731880 |
CLDN16
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144732570 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS144732617 |
DNAH17
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DNAH17-related disorder |
| RS144732839 |
OSGEP
|
Health Risk |
Likely pathogenic |
Galloway-Mowat syndrome 3, Galloway-Mowat syndrome 3 |
| RS144732922 |
LRPPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1447337068 |
PKP2
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Arrhythmogenic right ventricular dysplasia 9 |
| RS144733764 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS144734617 |
DNAH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144735319 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144735718 |
CIITA
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency |
| RS1447363475 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1447365901 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1447366650 |
SLC37A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucose-6-phosphate transport defect, Phosphate transport defect |
| RS1447368316 |
CPT1C
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 73, Hereditary spastic paraplegia 73 |
| RS1447370088 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS144737770 |
ITPR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1447379564 |
NKX2-1
|
Health Risk |
Pathogenic |
Brain-lung-thyroid syndrome, Brain-lung-thyroid syndrome |
| RS144738522 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA1-related disorder, LAMA1-related disorder |
| RS144738703 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1447391811 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Aortic valve disease 2 |
| RS144739747 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, IGF1R-related disorder |
| RS144740011 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA5-related disorder, LAMA5-related disorder |
| RS1447415684 |
TRIP11
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS1447417010 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Malignant tumor of urinary bladder |
| RS1447421194 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS144743617 |
FTO
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal polymalformative syndrome, Boissel type |
| RS144744182 |
PMPCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple mitochondrial dysfunctions syndrome 6, PMPCB-related disorder |
| RS144744401 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Intellectual disability |
| RS144744629 |
CEP104
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 25, Joubert syndrome and related disorders |
| RS144744634 |
HMGCS2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1447447724 |
SLC9A3
|
Health Risk |
Pathogenic |
Congenital secretory sodium diarrhea 8, Congenital secretory sodium diarrhea 8 |
| RS1447458978 |
UMOD
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Familial juvenile hyperuricemic nephropathy type 1 |
| RS144746030 |
STIL
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 7, primary |
| RS1447463543 |
COL2A1
|
Health Risk |
Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS1447465424 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS144746928 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS144747353 |
TBCE
|
Health Risk |
Conflicting classifications of pathogenicity |
TBCE-related disorder, TBCE-related disorder |
| RS1447478732 |
VPS53
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 2E, Pontocerebellar hypoplasia type 2E |
| RS144747878 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS144748043 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 |
| RS1447482674 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS144748816 |
PDYN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144748846 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1447498742 |
OTUD5
|
Health Risk |
Conflicting classifications of pathogenicity |
OTUD5-related disorder, OTUD5-related disorder |
| RS1447499380 |
PERCC1
|
Health Risk |
Likely pathogenic |
Diarrhea 11, malabsorptive |
| RS144750655 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS144750850 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS144751116 |
IL21R
|
Health Risk |
Conflicting classifications of pathogenicity |
Cryptosporidiosis-chronic cholangitis-liver disease syndrome, Inborn genetic diseases |
| RS144751329 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Cardiovascular phenotype |
| RS144751390 |
CTNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephropathic cystinosis, Ocular cystinosis |
| RS144751432 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Optic atrophy |
| RS1447523847 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1447532733 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS144754979 |
LRAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 14, Retinitis pigmentosa |
| RS144755294 |
SLC16A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spastic paraplegia |
| RS1447556321 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS144756110 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Ovarian serous cystadenocarcinoma |
| RS144756403 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Inborn genetic diseases |
| RS1447564693 |
CHRNB1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2A |
| RS144757200 |
PRICKLE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy type 5, Progressive myoclonic epilepsy |
| RS144757214 |
MITF
|
Health Risk |
Conflicting classifications of pathogenicity |
Tietz syndrome, Waardenburg syndrome type 2A |
| RS1447574915 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Drash syndrome |
| RS144758353 |
FARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS1447585760 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS144758871 |
SNCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lewy body dementia, Autosomal dominant Parkinson disease 1 |
| RS144759014 |
RASA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144759209 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS1447594194 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS144760517 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS144760921 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1447609804 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS144761543 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1C, USH1C-related disorder |
| RS144761622 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1447618526 |
MICAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144761853 |
ADGRG4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144762739 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
DDX41-related hematologic malignancy predisposition syndrome, Inborn genetic diseases |
| RS1447628856 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1447633595 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS144763522 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Inborn genetic diseases |
| RS144764160 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS144764222 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency, Granulomatous disease |
| RS144764663 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group B |
| RS144765020 |
SEC23A
|
Health Risk |
Conflicting classifications of pathogenicity |
Craniolenticulosutural dysplasia, Craniolenticulosutural dysplasia |
| RS144765242 |
KCND2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early myoclonic encephalopathy, Inborn genetic diseases |
| RS1447653524 |
EVC
|
Health Risk |
Pathogenic/Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS144766017 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitreoretinopathy, Wagner disease |
| RS1447665588 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS1447665931 |
LAMB3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS144766991 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS144767107 |
WDR72
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta hypomaturation type 2A3, Amelogenesis imperfecta hypomaturation type 2A3 |